| Literature DB >> 30149734 |
Anna Tivesten1, Nadim Akhtar2, Jessica Stolee3, Yannick Fillon3, Rachel Orr4, Malcolm L Hill4, Leo Van den Bergh5, Tom Huybrechts5, Jale Muslehiddinoglu5, Paul McCormac6, John Amery7, Andrea Brecht8, Achim Geiser8, Tobias Metzenthin9, Thomas Eichinger9.
Abstract
A consortium of seven pharma companies has been formed with the aim of sharing knowledge on and harmonizing approaches to oligonucleotide development. This letter aims to raise awareness of this new group and to set expectations for future publications.Entities:
Keywords: collaboration; consortium; harmonization; oligonucleotide; pre-competitive; prior knowledge
Mesh:
Substances:
Year: 2018 PMID: 30149734 DOI: 10.1177/2168479018793626
Source DB: PubMed Journal: Ther Innov Regul Sci ISSN: 2168-4790 Impact factor: 1.778